Personalized and precision medicine from diagnosis has changed the health paradigm in recent years and, as far as breast cancer is concerned, early diagnosis is a decisive factor. Faced with this reality, the Breast Pathology Center – Tejerina Foundation It has a team of specialized radiologists and the latest technology with the aim of maximizing the benefits of individualized breast examinations, essential in the face of this disease.
“Not all women are the same and, therefore, they need different follow-ups in their breast examinations. At the Breast Pathology Center – Fundación Tejerina we carry out an exhaustive study of the individual characteristics of each patient: personal and family history and risk factors (obesity; alcohol; breast density, one of the most important elements of decision regarding the type of follow-up, etc.) and, Through a diagnostic decision algorithm, we schedule an individualized breast examination for each womanthereby carrying out a complete study of the breast with the aim of ruling out or detecting breast cancer as early as possible”, says Dr. Armando Tejerina, scientific director of the Breast Pathology Center – Tejerina Foundation.
Furthermore, Dr. Tejerina adds that “In order to carry out this comprehensive analysis of each patient, it is essential to have a team of radiologists specialized in breast pathology”.
Dr. Alejandro Tejerina, director of the Diagnostic Imaging Area of the Breast Pathology Center – Fundación Tejerina, explains that “current mammography is accompanied by tomosynthesis, which we perform at the same time, in addition to normal mammography, tomographic cuts of the breast, which avoid overlapping tissue, such as a 3D mammogram that is especially useful in dense breasts. This has improved the test by increasing breast cancer detection rates by 35% and the sensitivity and specificity of mammography., significantly reducing indications for unnecessary biopsies. However, sometimes other tests are necessary, generally functional, such as contrast-enhanced mammography and breast magnetic resonance, which improve the results while maintaining the essence of that customized diagnosis”.
As far as magnetic resonance is concerned, the Breast Pathology Center – Fundación Tejerina implements a novel Abbreviated Protocol of Magnetic Resonance that allows the examination time to be reduced from 30 to 7 minutes with the same diagnostic effectiveness, which also improves the tolerance to the test on the part of the patients. With this innovative protocol, the organization demonstrates once again his commitment and work to always be at the forefront incorporating the latest technological advances in the diagnosis and treatment of breast cancer and offering personalized medicine to each of his patients.
Also, according to the Spanish Society of Medical Oncology (SEOM), in 2023 breast cancer will be the most frequently diagnosed tumor (35,001) in women. Survival against this disease is 86% and in 2020 its prevalence at five years was 516,827.
